Point Biopharma finds big licensing partner, but stock falls after Q3 loss widens

Retrieved on: 2022-11-14 20:37:43

Tags for this article:

Click the tags to see associated articles and topics

Point Biopharma finds big licensing partner, but stock falls after Q3 loss widens. View article details on hiswai:

Excerpt

Point Biopharma, which is developing targeted drugs for the treatment of cancer, said it had entered a licensing deal with Lantheus Holdings, a large ...

Article found on: www.ibj.com

View Original Article